Genscript Biotech Corporation (HKG:1548)
Hong Kong · Delayed Price · Currency is HKD 17.66
+0.33 (1.90%)
Oct 8, 2025, 4:08 PM HKT
Genscript Biotech Market Cap
Genscript Biotech has a market cap or net worth of 38.59 billion as of October 8, 2025. Its market cap has increased by 60.44% in one year.
Market Cap
38.59B
Enterprise Value
35.57B
Revenue
6.50B
Ranking
n/a
PE Ratio
1.58
Stock Price
17.66
Market Cap Chart
Since December 30, 2015, Genscript Biotech's market cap has increased from 2.11B to 38.59B, an increase of 1,727.12%. That is a compound annual growth rate of 34.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 37.87B | 79.50% |
| Dec 31, 2024 | 21.10B | -49.96% |
| Dec 29, 2023 | 42.16B | -19.78% |
| Dec 30, 2022 | 52.56B | -27.50% |
| Dec 31, 2021 | 72.50B | 229.03% |
| Dec 31, 2020 | 22.03B | -33.64% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 294.55B |
| Hansoh Pharmaceutical Group Company | 234.53B |
| JD Health International | 207.30B |
| Innovent Biologics | 172.13B |
| WuXi Biologics | 170.68B |
| Sino Biopharmaceutical | 148.38B |
| Sichuan Kelun-Biotech Biopharmaceutical | 130.93B |
| Akeso | 130.16B |